Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 94 Pages
Report ld: 3487541
Request Sample
Customized Report
The global market for Extracellular Matrix Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Extracellular Matrix Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Extracellular Matrix Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Extracellular Matrix Patch include Cook Group, Medtronic, Admedus, Boston Scientific Corporation, Baxter International, BD, Terumo Corporation, LeMaitre, Smith+Nephew, Aziyo Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Extracellular Matrix Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracellular Matrix Patch.
The Extracellular Matrix Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Extracellular Matrix Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracellular Matrix Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cook Group
Medtronic
Admedus
Boston Scientific Corporation
Baxter International
BD
Terumo Corporation
LeMaitre
Smith+Nephew
Aziyo Biologics
Integra LifeSciences Corporation
Coloplast, Medtronic
MTF Biologics
Koninklijke DSM
Segment by Type
Bovine
Porcine
Others
Segment by Application
Cardiac Repair
Vascular Repair & Reconstruction
Pericardial Repair
Dural Repair
Soft Tissue Repair
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Extracellular Matrix Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Extracellular Matrix Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Extracellular Matrix Patch Market Overview
1.1 Product Definition
1.2 Extracellular Matrix Patch by Type
1.2.1 Global Extracellular Matrix Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bovine
1.2.3 Porcine
1.2.4 Others
1.3 Extracellular Matrix Patch by Application
1.3.1 Global Extracellular Matrix Patch Market Value by Application (2024 VS 2031)
1.3.2 Cardiac Repair
1.3.3 Vascular Repair & Reconstruction
1.3.4 Pericardial Repair
1.3.5 Dural Repair
1.3.6 Soft Tissue Repair
1.3.7 Others
1.4 Global Extracellular Matrix Patch Market Size Estimates and Forecasts
1.4.1 Global Extracellular Matrix Patch Revenue 2020-2031
1.4.2 Global Extracellular Matrix Patch Sales 2020-2031
1.4.3 Global Extracellular Matrix Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Extracellular Matrix Patch Market Competition by Manufacturers
2.1 Global Extracellular Matrix Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Extracellular Matrix Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Extracellular Matrix Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Extracellular Matrix Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Extracellular Matrix Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Extracellular Matrix Patch, Product Type & Application
2.7 Global Key Manufacturers of Extracellular Matrix Patch, Date of Enter into This Industry
2.8 Global Extracellular Matrix Patch Market Competitive Situation and Trends
2.8.1 Global Extracellular Matrix Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Extracellular Matrix Patch Players Market Share by Revenue
2.8.3 Global Extracellular Matrix Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Extracellular Matrix Patch Market Scenario by Region
3.1 Global Extracellular Matrix Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Extracellular Matrix Patch Sales by Region: 2020-2031
3.2.1 Global Extracellular Matrix Patch Sales by Region: 2020-2025
3.2.2 Global Extracellular Matrix Patch Sales by Region: 2026-2031
3.3 Global Extracellular Matrix Patch Revenue by Region: 2020-2031
3.3.1 Global Extracellular Matrix Patch Revenue by Region: 2020-2025
3.3.2 Global Extracellular Matrix Patch Revenue by Region: 2026-2031
3.4 North America Extracellular Matrix Patch Market Facts & Figures by Country
3.4.1 North America Extracellular Matrix Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Extracellular Matrix Patch Sales by Country (2020-2031)
3.4.3 North America Extracellular Matrix Patch Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Extracellular Matrix Patch Market Facts & Figures by Country
3.5.1 Europe Extracellular Matrix Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Extracellular Matrix Patch Sales by Country (2020-2031)
3.5.3 Europe Extracellular Matrix Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Extracellular Matrix Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Extracellular Matrix Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Extracellular Matrix Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Extracellular Matrix Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Extracellular Matrix Patch Market Facts & Figures by Country
3.7.1 Latin America Extracellular Matrix Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Extracellular Matrix Patch Sales by Country (2020-2031)
3.7.3 Latin America Extracellular Matrix Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Extracellular Matrix Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Extracellular Matrix Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Extracellular Matrix Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Extracellular Matrix Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Extracellular Matrix Patch Sales by Type (2020-2031)
4.1.1 Global Extracellular Matrix Patch Sales by Type (2020-2025)
4.1.2 Global Extracellular Matrix Patch Sales by Type (2026-2031)
4.1.3 Global Extracellular Matrix Patch Sales Market Share by Type (2020-2031)
4.2 Global Extracellular Matrix Patch Revenue by Type (2020-2031)
4.2.1 Global Extracellular Matrix Patch Revenue by Type (2020-2025)
4.2.2 Global Extracellular Matrix Patch Revenue by Type (2026-2031)
4.2.3 Global Extracellular Matrix Patch Revenue Market Share by Type (2020-2031)
4.3 Global Extracellular Matrix Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Extracellular Matrix Patch Sales by Application (2020-2031)
5.1.1 Global Extracellular Matrix Patch Sales by Application (2020-2025)
5.1.2 Global Extracellular Matrix Patch Sales by Application (2026-2031)
5.1.3 Global Extracellular Matrix Patch Sales Market Share by Application (2020-2031)
5.2 Global Extracellular Matrix Patch Revenue by Application (2020-2031)
5.2.1 Global Extracellular Matrix Patch Revenue by Application (2020-2025)
5.2.2 Global Extracellular Matrix Patch Revenue by Application (2026-2031)
5.2.3 Global Extracellular Matrix Patch Revenue Market Share by Application (2020-2031)
5.3 Global Extracellular Matrix Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cook Group
6.1.1 Cook Group Company Information
6.1.2 Cook Group Description and Business Overview
6.1.3 Cook Group Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cook Group Extracellular Matrix Patch Product Portfolio
6.1.5 Cook Group Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Extracellular Matrix Patch Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Admedus
6.3.1 Admedus Company Information
6.3.2 Admedus Description and Business Overview
6.3.3 Admedus Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Admedus Extracellular Matrix Patch Product Portfolio
6.3.5 Admedus Recent Developments/Updates
6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Company Information
6.4.2 Boston Scientific Corporation Description and Business Overview
6.4.3 Boston Scientific Corporation Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boston Scientific Corporation Extracellular Matrix Patch Product Portfolio
6.4.5 Boston Scientific Corporation Recent Developments/Updates
6.5 Baxter International
6.5.1 Baxter International Company Information
6.5.2 Baxter International Description and Business Overview
6.5.3 Baxter International Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Baxter International Extracellular Matrix Patch Product Portfolio
6.5.5 Baxter International Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BD Extracellular Matrix Patch Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Terumo Corporation
6.7.1 Terumo Corporation Company Information
6.7.2 Terumo Corporation Description and Business Overview
6.7.3 Terumo Corporation Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Terumo Corporation Extracellular Matrix Patch Product Portfolio
6.7.5 Terumo Corporation Recent Developments/Updates
6.8 LeMaitre
6.8.1 LeMaitre Company Information
6.8.2 LeMaitre Description and Business Overview
6.8.3 LeMaitre Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LeMaitre Extracellular Matrix Patch Product Portfolio
6.8.5 LeMaitre Recent Developments/Updates
6.9 Smith+Nephew
6.9.1 Smith+Nephew Company Information
6.9.2 Smith+Nephew Description and Business Overview
6.9.3 Smith+Nephew Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Smith+Nephew Extracellular Matrix Patch Product Portfolio
6.9.5 Smith+Nephew Recent Developments/Updates
6.10 Aziyo Biologics
6.10.1 Aziyo Biologics Company Information
6.10.2 Aziyo Biologics Description and Business Overview
6.10.3 Aziyo Biologics Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aziyo Biologics Extracellular Matrix Patch Product Portfolio
6.10.5 Aziyo Biologics Recent Developments/Updates
6.11 Integra LifeSciences Corporation
6.11.1 Integra LifeSciences Corporation Company Information
6.11.2 Integra LifeSciences Corporation Description and Business Overview
6.11.3 Integra LifeSciences Corporation Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Integra LifeSciences Corporation Extracellular Matrix Patch Product Portfolio
6.11.5 Integra LifeSciences Corporation Recent Developments/Updates
6.12 Coloplast, Medtronic
6.12.1 Coloplast, Medtronic Company Information
6.12.2 Coloplast, Medtronic Description and Business Overview
6.12.3 Coloplast, Medtronic Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Coloplast, Medtronic Extracellular Matrix Patch Product Portfolio
6.12.5 Coloplast, Medtronic Recent Developments/Updates
6.13 MTF Biologics
6.13.1 MTF Biologics Company Information
6.13.2 MTF Biologics Description and Business Overview
6.13.3 MTF Biologics Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 MTF Biologics Extracellular Matrix Patch Product Portfolio
6.13.5 MTF Biologics Recent Developments/Updates
6.14 Koninklijke DSM
6.14.1 Koninklijke DSM Company Information
6.14.2 Koninklijke DSM Description and Business Overview
6.14.3 Koninklijke DSM Extracellular Matrix Patch Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Koninklijke DSM Extracellular Matrix Patch Product Portfolio
6.14.5 Koninklijke DSM Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Extracellular Matrix Patch Industry Chain Analysis
7.2 Extracellular Matrix Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Extracellular Matrix Patch Production Mode & Process Analysis
7.4 Extracellular Matrix Patch Sales and Marketing
7.4.1 Extracellular Matrix Patch Sales Channels
7.4.2 Extracellular Matrix Patch Distributors
7.5 Extracellular Matrix Patch Customer Analysis
8 Extracellular Matrix Patch Market Dynamics
8.1 Extracellular Matrix Patch Industry Trends
8.2 Extracellular Matrix Patch Market Drivers
8.3 Extracellular Matrix Patch Market Challenges
8.4 Extracellular Matrix Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Extracellular Matrix Patch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 142
USD 3950.00
(Single User License)
The global Extracellular Matrix Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 118
USD 2900.00
(Single User License)
The global Extracellular Matrix Patch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 93
USD 4250.00
(Single User License)
The global Extracellular Matrix Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 152
USD 4900.00
(Single User License)
The global market for Extracellular Matrix Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 128
USD 3950.00
(Single User License)
The global Extracellular Matrix Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-05
Pages: 87
USD 2900.00
(Single User License)
The global market for Extracellular Matrix Patch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 142
The global Extracellular Matrix Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 118
The global Extracellular Matrix Patch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 93
The global Extracellular Matrix Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 152
The global market for Extracellular Matrix Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 128
The global Extracellular Matrix Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-05
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now